UK evidence-led drug information
UK Drug Trends Intelligence ↗TD Consultancy ↗
Drug familyUK guide

Opioids

Opioids are a drug family that includes heroin/diamorphine, morphine, codeine, methadone, buprenorphine, oxycodone, fentanyl and nitazenes. Potency, duration, medical use and legal controls differ substantially.

Reviewed 5 August 2026Legal information checked 5 August 2026Responsible organisation TD Consultancy
Harm-reduction editorial still life representing opioids with a neutral powder sample and unbranded naloxone-style nasal device

Appearance varies. A substance cannot be reliably identified by colour, shape, packaging or an image.

Overview

What is Opioids?

Common and street names

opiates · painkillers · opioid medicines

Drug category

Drug family

Forms and appearance

Opioids include powders, tablets, patches, liquids and prescribed formulations. The family is chemically and legally diverse.

How it is commonly used

Routes depend on the specific opioid and formulation. Using a medicine in a route it was not designed for can change absorption and risk.

Brain & body

How Opioids affects signalling and behaviour

Many opioids activate mu-opioid receptors involved in pain, reward and breathing. The same pharmacology that can reduce pain can also suppress respiration, especially with high exposure or other depressants.

Effects & risks

What people may experience — and what can go wrong

Commonly reported effects

  • Pain relief
  • Sedation
  • Euphoria or relief
  • Constipation and slowed breathing

Short-term risks

  • Respiratory depression and overdose
  • Loss of consciousness and aspiration
  • Unpredictable potency
  • Higher risk when mixed with sedatives

Longer-term risks

  • Tolerance and dependence
  • Overdose after tolerance loss
  • Constipation and endocrine effects with some long-term use
  • Social and health harms shaped by access, supply and treatment

Mental-health effects

Opioid use can become closely linked with trauma, pain, stress, sleep and emotional regulation. Assessment should explore the function of use as well as frequency and quantity.

Dependence, tolerance & withdrawal

Repeated use can change the pattern

Dependence can be treated. Methadone and buprenorphine are evidence-based opioid agonist treatments in the UK, alongside psychosocial and practical support. Goals should be individualised.

Mixing drugs

Interaction risks to know

01

Opioids + benzodiazepines: particularly high overdose risk.

02

Opioids + alcohol or GHB/GBL: additive sedation and respiratory depression.

03

Multiple opioid products can unintentionally stack exposure.

No combination is labelled safe.

The absence of a recorded interaction does not mean that a combination is safe. Strength, dose, health, tolerance, contamination and other substances can alter risk.

Check another combination

Harm reduction

Practical ways to reduce risk

1

Carry naloxone and learn to recognise opioid overdose.

2

Avoid mixing opioids with alcohol or other sedatives.

3

After any period of abstinence, assume tolerance has fallen.

4

Seek treatment without waiting for use to become 'severe enough'.

Harm reduction can reduce some risks; it cannot make an unregulated drug, dose or combination risk-free.

Emergency

When to call 999

  • Unresponsive or cannot be woken
  • Abnormal or absent breathing
  • Blue/grey lips or skin
  • Suspected opioid overdose: call 999 and give naloxone if available
If in doubt in a suspected drug emergency, call 999 and describe what you can see. Do not wait for certainty about the substance.

Treatment & support

Help does not require one fixed recovery goal

UK drug and alcohol services can assess physical health, mental health, dependence, risk, housing and support needs, then agree a plan with the person. Goals may include immediate harm reduction, stabilisation, reduction or stopping use.

Dependence can be treated. Methadone and buprenorphine are evidence-based opioid agonist treatments in the UK, alongside psychosocial and practical support. Goals should be individualised.

Brief history

How we got here

Humans have used opium for millennia. Morphine, heroin and later synthetic opioids changed medicine and illicit markets; modern UK practice combines pain medicine controls with evidence-based opioid-dependence treatment and naloxone provision.

Read the history guide

Key facts & misconceptions

Three useful corrections

01

Prescription status does not remove opioid overdose risk.

02

Dependence is treatable and is not a failure of willpower.

03

Naloxone does not encourage drug use; it reverses opioid effects temporarily.

Frequently asked questions

Quick answers

What type of drug is Opioids?

Opioids is described here as drug family. Some drugs cross categories, and mixtures may contain more than one drug type.

Can Opioids be identified by appearance?

No. Appearance, packaging, a logo or colour cannot reliably establish identity, strength or contamination.

When should I call 999?

Call 999 for a suspected drug emergency, including reduced consciousness, abnormal breathing, seizure, severe chest pain or severe confusion. Unresponsive or cannot be woken

Evidence & governance

Sources and review

Responsible organisation: TD Consultancy
Published: 5 August 2026 · Last reviewed: 5 August 2026
Next formal review: February 2027, or earlier if material safety or legal information changes.

Evidence on illicit drug composition and emerging markets can change quickly. Legal status can be compound- and preparation-specific. Links below are prioritised to current official UK guidance.